Paper42865699PubMed
A smart MMP-9-responsive hydrogel releasing quercetin for psoriasis therapy.
Lan Q and 7 others. Front Pharmacol, 2026.
Cite this record
ConductScience Library. A smart MMP-9-responsive hydrogel releasing quercetin for psoriasis therapy. Papers, record 42865699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42865699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A smart MMP-9-responsive hydrogel releasing quercetin for psoriasis therapy.
- Journal
- Front Pharmacol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-14
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23308107 | Cross-study homogeneity of psoriasis gene expression in skin across a large expression range. | PLoS One | 2013 | https://conductscience.org/library/papers/23308107 | PubMed |
| 2 | 34067151 | Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34067151 | PubMed |
| 3 | 38612660 | Advancements in Regenerative Hydrogels in Skin Wound Treatment: A Comprehensive Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612660 | PubMed |
| 4 | 39808370 | Topical Anti-Inflammatory Effects of Quercetin Glycosides on Atopic Dermatitis-Like Lesions: Influence of the Glycone Type on Efficacy and Skin Absorption. | Inflammation | 2025 | https://conductscience.org/library/papers/39808370 | PubMed |
| 5 | 22479649 | Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis. | PLoS One | 2012 | https://conductscience.org/library/papers/22479649 | PubMed |
| 6 | 39757860 | Exploring the Therapeutic Effects of Anisole on Psoriasis in Mice Based on the JAK1/STAT3 Pathway. | Phytother Res | 2025 | https://conductscience.org/library/papers/39757860 | PubMed |
| 7 | 30188112 | Quercetin Inlaid Silk Fibroin/Hydroxyapatite Scaffold Promotes Enhanced Osteogenesis. | ACS Appl Mater Interfaces | 2018 | https://conductscience.org/library/papers/30188112 | PubMed |
| 8 | 10397904 | Synthesis of superporous hydrogels: hydrogels with fast swelling and superabsorbent properties. | J Biomed Mater Res | 1999 | https://conductscience.org/library/papers/10397904 | PubMed |
| 9 | 29035818 | Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model. | Colloids Surf B Biointerfaces | 2017 | https://conductscience.org/library/papers/29035818 | PubMed |
| 10 | 39089547 | Hydrogels comprising oxidized carboxymethyl cellulose and water-soluble chitosan at varied oxidation levels: Synthesis, characterization, and adsorptive toward methylene blue. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/39089547 | PubMed |
| 11 | 34971873 | Quercetin derivatives: Drug design, development, and biological activities, a review. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/34971873 | PubMed |
| 12 | 36430891 | Synthetic Pathways and the Therapeutic Potential of Quercetin and Curcumin. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430891 | PubMed |
| 13 | 33052243 | Bioinspired biliverdin/silk fibroin hydrogel for antiglioma photothermal therapy and wound healing. | Theranostics | 2020 | https://conductscience.org/library/papers/33052243 | PubMed |
| 14 | 19169254 | Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. | Nat Genet | 2009 | https://conductscience.org/library/papers/19169254 | PubMed |
| 15 | 38513823 | Matrix metalloproteinase landscape in the imiquimod-induced skin inflammation mouse model. | Biochimie | 2024 | https://conductscience.org/library/papers/38513823 | PubMed |
| 16 | 41135443 | Glycyrrhizic acid-containing Gastrodia elata polysaccharide/chitosan hydrogel promotes macrophage M2 polarization and accelerates aging skin wound healing. | Biomater Adv | 2026 | https://conductscience.org/library/papers/41135443 | PubMed |
| 17 | 37584330 | Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37584330 | PubMed |
| 18 | 11752295 | Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. | Nucleic Acids Res | 2002 | https://conductscience.org/library/papers/11752295 | PubMed |
| 19 | 36618400 | Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis. | Front Immunol | 2022 | https://conductscience.org/library/papers/36618400 | PubMed |
| 20 | 32888954 | Neutrophils Enhance Cutaneous Vascular Dilation and Permeability to Aggravate Psoriasis by Releasing Matrix Metallopeptidase 9. | J Invest Dermatol | 2021 | https://conductscience.org/library/papers/32888954 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42865699
GET https://conductscience.org/api/papers/v1/42865699/references?page=2